Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 AUD | -6.67% | +18.31% | +21.74% |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
Apr. 24 | Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 348M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep : Completes Patient Enrollment in Stage 2 of Part B of NSCLC Study; Shares Drop Early